" class="no-js "lang="en-US"> Biopharmaceutical Archives - Medtech Alert
Wednesday, March 22, 2023

Sort by:


Top Post

Sage Therapeutics Appoints Jessica Federer to Board of Directors

Sage Therapeutics, a biopharmaceutical company leading the way to create a world with better brain […]

Personalis Selected for Clinical Research by AstraZeneca After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay

Personalis, a leader in advanced genomics for precision oncology, today announced it will continue its […]

Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform

Prokarium, a biopharmaceutical company leading the oncology field of microbial immunotherapy, has raised $30 million […]

Tvardi Therapeutics Appoints John Kauh, M.D. as Chief Medical Officer

Tvardi Therapeutics, a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, […]

Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer

Scholar Rock, a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases […]

Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe

Trelleborg Healthcare & Medical announces a substantial investment to expand its European biopharmaceutical manufacturing capabilities […]

Quince Therapeutics Completes the Sale of Legacy Protease Inhibitor Portfolio to Lighthouse Pharmaceuticals

Quince Therapeutics, a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, announced […]

Tallac Therapeutics Appoints Kevin N. Heller, M.D., as Chief Medical Officer

Tallac Therapeutics, a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity […]

Tigermed Completes Acquisition of Marti Farm

Tigermed, a leading global provider of clinical research solutions across the full lifecycle of global […]

IASO Bio Raises Nearly $75 Million in Series C1 Funding

IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative […]

  1. Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors Read more
  2. Coya Therapeutics Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA 302 in Amyotrophic Lateral Sclerosis (ALS) Read more
  3. BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey Read more
  4. Mindset Health Raises $12M to Expand Digital Hypnotherapy Apps & Scale Distribution Read more
  5. GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey” Read more